New Brunswick Reports Blood Clot Death in Connection With Oxford AstraZeneca Vaccine

Pharmacist Barbara Violo arranges all the empty vials of the Oxford-AstraZeneca COVID-19 vaccines that she has provided to customers at the Junction Chemist which is a independent pharmacy during the COVID-19 pandemic in Toronto, on April 19, 2021. THE CANADIAN PRESS/Nathan Denette

FREDERICTON—New Brunswick health officials are reporting the province’s first death of someone who developed a blood clot after receiving the Oxford-AstraZeneca vaccine.

The individual in their 60s received the vaccine in mid-April and developed symptoms a week later, chief medical officer of health Dr. Jennifer Russell told reporters Wednesday. She said the person, whose gender was not disclosed, was admitted to hospital and died two days later.